Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.01. | Optinose, Inc.: Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice | 84 | GlobeNewswire (Europe) | XHANCE significantly reduced both symptoms and sinus opacification in participants with chronic sinusitis (chronic rhinosinusitis) in two randomized controlled Phase 3 Clinical Trials (ReOpen1 and... ► Artikel lesen | |
18.01. | OrderYOYO A/S: OrderYOYO publishes ARR, Net Revenue and EBITDA significantly above latest guidance. 2024 guidance significantly raised | 127 | GlobeNewswire (Europe) | Company Announcement No. 69 - 2024
OrderYOYO A/S
Inside InformationCopenhagen, January 18, 2024
Highlights
Business continues to perform strongly and above guidance. Highly focused strategy... ► Artikel lesen | |
18.01. | Etteplan Oyj: Etteplan issues a profit warning: according to the preliminary result, Etteplan's revenue for 2023 is about EUR 359 million and the operating profit (EBIT) is about EUR 25.4 million | 101 | GlobeNewswire (Europe) | Etteplan Oyj, Stock Exchange Release/Insider information, January 18, 2024 at 8 a.m. EET
Etteplan issues a profit warning
According to the preliminary result, Etteplan's revenue for 2023 is about... ► Artikel lesen | |
18.01. | Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination | 203 | GlobeNewswire (Europe) | WEST HOLLYWOOD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. ("Bannix") announced today that its board of directors (the "Board") has decided to extend the date by which Bannix... ► Artikel lesen | |
18.01. | Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap | 240 | GlobeNewswire (Europe) | REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12. Axoguard Nerve... ► Artikel lesen | |
18.01. | GH Research PLC: GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression | 201 | GlobeNewswire (Europe) | DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological... ► Artikel lesen | |
18.01. | Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024 | 190 | GlobeNewswire (Europe) | NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd. ("Aimei") announced today that, commencing January 22, 2024, holders of the units sold in the Company's initial public... ► Artikel lesen | |
18.01. | Arisz Acquisition Corp. Announces Extension of Deadline to Complete Business Combination | 90 | GlobeNewswire (Europe) | New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Arisz Acquisition Corp. (NASDAQ: ARIZ ("Arisz" or the "Company"), a special purpose acquisition company, announced today that Arisz Investments LLC... ► Artikel lesen | |
18.01. | Mesa Air Group, Inc.: Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program | 322 | GlobeNewswire (Europe) | PHOENIX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) ("Mesa" or the "Company") today announced agreements with United Airlines ("United") to amend its capacity purchase agreement... ► Artikel lesen | |
18.01. | OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results | 1.998 | GlobeNewswire (Europe) | RED BANK, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp. (NASDAQ:"OCFC") (the "Company"), the holding company for OceanFirst Bank N.A. (the "Bank"), announced net income available... ► Artikel lesen | |
18.01. | Bioventus, Inc.: Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility | 338 | GlobeNewswire (Europe) | DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today announced that it has entered... ► Artikel lesen | |
18.01. | Bird Construction Inc: Bird Bolsters Capabilities, Capacity, and Recurring Revenue With Agreement to Acquire Leading Alberta Electrical Service Provider | 264 | GlobeNewswire (Europe) | MISSISSAUGA, Ontario, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bird Construction Inc. (TSX: BDT) announced today that it has acquired the assets of NorCan Electric Inc. ("NorCan") for a total consideration... ► Artikel lesen | |
18.01. | GitLab Inc.: GitLab Appoints Sabrina Farmer as Chief Technology Officer | 541 | GlobeNewswire (Europe) | SAN FRANCISCO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- All Remote - GitLab Inc., the most comprehensive AI-powered DevSecOps platform, today announced the appointment of Sabrina Farmer as its chief technology... ► Artikel lesen | |
18.01. | SEALSQ Unveils AIoT Strategy with WISeAI.IO at Davos AI Roundtable | 462 | GlobeNewswire (Europe) |
Davos, Switzerland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp ("SEALSQ" or "Company") (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology... ► Artikel lesen | |
18.01. | Phaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024 | 464 | GlobeNewswire (Europe) | Lyon (France) and Cambridge (MA, US), January 18, 2024, at 10:05pm CET - PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and... ► Artikel lesen | |
18.01. | QIAGEN N.V.: QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million | 444 | GlobeNewswire (Europe) | Venlo, the Netherlands, Jan. 18, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced details for completion of the synthetic share repurchase plan to return... ► Artikel lesen | |
18.01. | NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders | 331 | GlobeNewswire (Europe) | BELTSVILLE, Md., Jan. 18, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines... ► Artikel lesen | |
18.01. | Ikena Oncology, Inc.: Ikena Oncology Outlines Key Priorities and Provides Corporate Updates | 393 | GlobeNewswire (Europe) | IK-930 optimized formulation now in the clinic; on track to deliver additional monotherapy data in 2H 2024 IK-595 first cohort treated and cleared safety evaluation window Focused execution on core... ► Artikel lesen | |
18.01. | Bank OZK Announces Record Fourth Quarter and Full Year 2023 Earnings | 404 | GlobeNewswire (Europe) | LITTLE ROCK, Ark., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bank OZK (the "Bank") (Nasdaq: OZK) today announced that net income available to common stockholders for the fourth quarter of 2023 was a record... ► Artikel lesen | |
18.01. | PMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway | 345 | GlobeNewswire (Europe) | Prioritization of PC14586 development and focused discovery research efforts results in a workforce reduction of approximately 30%Unaudited cash, cash equivalents, and marketable securities totaling... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 4.005 |
EVOTEC | 3.195 |
TUI | 2.818 |
NVIDIA | 2.768 |
BAYER | 2.667 |
NEL | 2.485 |
RENK GROUP | 1.792 |
RHEINMETALL | 1.714 |
TESLA | 1.308 |
PALANTIR TECHNOLOGIES | 1.291 |
VOLKSWAGEN | 1.271 |
DEUTSCHE BANK | 1.155 |
PLUG POWER | 1.080 |
BYD | 1.048 |
AMAZON | 1.046 |
MICROSTRATEGY | 1.046 |
PROSIEBENSAT.1 | 1.034 |
BASF | 1.025 |
COMMERZBANK | 1.023 |
MERCEDES-BENZ | 952 |
THYSSENKRUPP | 937 |
JINKOSOLAR | 893 |
ALLIANZ | 890 |
AIXTRON SE | 886 |
DEUTSCHE TELEKOM | 881 |